These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4357869)

  • 1. Inhibitory action of Ruthenium red on neuromuscular transmission.
    Rahamimoff R; Alnaes E
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3613-6. PubMed ID: 4357869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of mitochondria in transmitter release from motor nerve terminals.
    Alnaes E; Rahamimoff R
    J Physiol; 1975 Jun; 248(2):285-306. PubMed ID: 50439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of chlorpromazine at an isolated cholinergic synapse.
    Argov Z; Yaari Y
    Brain Res; 1979 Mar; 164():227-36. PubMed ID: 218686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline augments tetanic potentiation of transmitter release by a calcium dependent process.
    Bergman H; Glusman S; Harris-Warrick RM; Kravitz EA; Nussinovitch I; Rahamimoff R
    Brain Res; 1981 Jun; 214(1):200-4. PubMed ID: 6263418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission.
    Lee DC; Kim YI; Liu HH; Johns TR
    Muscle Nerve; 1983; 6(6):442-7. PubMed ID: 6312309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of spontaneous and ionophore-induced transmitter release by ruthenium red at the neuromuscular junction.
    Person RJ; Kuhn JA
    Brain Res Bull; 1979; 4(5):669-74. PubMed ID: 487223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of synaptic transmission by diphenylhydantoin.
    Yaari Y; Pincus JH; Argov Z
    Ann Neurol; 1977 Apr; 1(4):334-8. PubMed ID: 31132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine-induced depression of neuromuscular transmission.
    Chinyanga HM; Vartanian GA; Okai EA; Greenberger DV
    Eur J Pharmacol; 1972 May; 18(2):256-60. PubMed ID: 4338758
    [No Abstract]   [Full Text] [Related]  

  • 12. Ruthenium red reduces acetylcholine sensitivity and increases desensitization at the frog neuromuscular junction.
    Ribera AB; Nastuk WL
    Neuroscience; 1987 Nov; 23(2):739-44. PubMed ID: 2449634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium and quantal release of transmitter at the neuromuscular junction.
    Dodge FA; Miledi R; Rahamimoff R
    J Physiol; 1969 Jan; 200(1):267-83. PubMed ID: 4387376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic aspects of neuromuscular transmission and block.
    Foldes FF
    Anaesthesist; 1971 Jan; 20(1):6-19. PubMed ID: 4322998
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin and transmitter release at the neuromuscular junction of the frog.
    Yaari Y; Pincus JH; Argov Z
    Brain Res; 1979 Jan; 160(3):479-87. PubMed ID: 33744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin reduces frequency potentiation of synaptic potentials at the frog neuromuscular junction.
    Selzer ME; David G; Yaari Y
    Brain Res; 1984 Jun; 304(1):149-52. PubMed ID: 6744034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of batrachotoxin. II. Effect on electrical properties of the mammalian nerve and skeletal muscle membranes.
    Albuquerque EX; Warnick JE; Sansone FM
    J Pharmacol Exp Ther; 1971 Mar; 176(3):511-28. PubMed ID: 4329452
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmitter release from nerve terminals undergoing suppression.
    Wigston DJ
    Brain Res; 1980 May; 190(1):175-83. PubMed ID: 6103730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.